These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 17163159)
41. The impact of molecular diagnostic tests on patient outcomes. Ross JS Clin Lab Med; 1999 Dec; 19(4):815-31, vi-vii. PubMed ID: 10572717 [TBL] [Abstract][Full Text] [Related]
42. [Positive and negative aspects of genetic testing for familial cancer]. Ohye T; Kurahashi H Nihon Geka Gakkai Zasshi; 2014 Jan; 115(1):34-8. PubMed ID: 24597336 [No Abstract] [Full Text] [Related]
43. Pricey cancer genome project struggles with sample shortage. Waltz E Nat Med; 2007 Apr; 13(4):391. PubMed ID: 17415360 [No Abstract] [Full Text] [Related]
44. [Human, economics and social sciences: rebounds of ideas on genomics and clinical trials]. Julian-Reynier C Med Sci (Paris); 2012 Mar; 28 Spec No 1():3-4. PubMed ID: 22494647 [No Abstract] [Full Text] [Related]
45. Nucleic acids in diagnosis (Part II): Genetic testing and screening. Datar RH Natl Med J India; 2001; 14(2):93-8. PubMed ID: 11396327 [No Abstract] [Full Text] [Related]
46. Molecular markers in cancer diagnosis. Sidransky D J Natl Cancer Inst Monogr; 1995; (17):27-9. PubMed ID: 8573448 [TBL] [Abstract][Full Text] [Related]
47. [Genetic testing and gene-based testing for familial tumor]. Sugano K Nihon Rinsho; 2005 Dec; 63 Suppl 12():191-5. PubMed ID: 16416793 [No Abstract] [Full Text] [Related]
48. Epigenetics: origins and implications for cancer epidemiology. Nise MS; Falaturi P; Erren TC Med Hypotheses; 2010 Feb; 74(2):377-82. PubMed ID: 19818564 [TBL] [Abstract][Full Text] [Related]
49. [Current state and prospect of molecular pathology of lung cancer]. Jia X Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):325-7. PubMed ID: 12790102 [No Abstract] [Full Text] [Related]
50. Molecular pathology, Part 3. Is a career in molecular pathology for you? Klosinski DD MLO Med Lab Obs; 1995 Jul; 27(7):38-40, 42. PubMed ID: 10144252 [No Abstract] [Full Text] [Related]
51. Clinical selection of candidates for mutational testing for cancer susceptibility. Lynch HT; Lynch PM Oncology (Williston Park); 2006 Dec; 20(14 Suppl 10):29-34. PubMed ID: 17354515 [TBL] [Abstract][Full Text] [Related]
52. The new age of healthcare. Laskaris JX Radiol Manage; 2002; 24(6):14-6. PubMed ID: 12510605 [No Abstract] [Full Text] [Related]
55. Cancer family history and genetic testing: are malpractice adjudications waiting to happen? Lynch HT Am J Gastroenterol; 2002 Mar; 97(3):518-20. PubMed ID: 11922540 [No Abstract] [Full Text] [Related]
56. [Predictive medicine - clinical genetics 2010]. Blum HE Dtsch Med Wochenschr; 2010 Jun; 135(25-26):1334-8. PubMed ID: 20556694 [No Abstract] [Full Text] [Related]
57. Changing trends in laboratory testing in the United States: a personal, historical perspective. Strom CM Clin Lab Med; 2012 Dec; 32(4):651-64. PubMed ID: 23078665 [TBL] [Abstract][Full Text] [Related]
58. DNA diagnosis and the emergence of cancer genetic services in European health care. Stemerding D; Koch L; Bourret P Eur J Hum Genet; 1997; 5 Suppl 2():25-30. PubMed ID: 9450191 [No Abstract] [Full Text] [Related]